zeltiq aesthetics inc (ZLTQ:NASDAQ GS)
zeltiq aesthetics inc (ZLTQ) Snapshot
|
Open
$4.99
|
Previous Close
$4.97
|
|
|
Day High
$5.07
|
Day Low
$4.98
|
|
|
52 Week High
10/17/12 - $7.08
|
52 Week Low
04/2/13 - $3.20
|
|
|
Market Cap
182.5M
|
Average Volume 10 Days
68.9K
|
|
|
EPS TTM
$-0.78
|
Shares Outstanding
36.0M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
zeltiq aesthetics inc (ZLTQ) Related Businessweek News
No Related Businessweek News Foundzeltiq aesthetics inc (ZLTQ) Details
ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. The company offers CoolSculpting System, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges that may not respond to diet or exercise. It sells its products through a network of distributors, as well as direct sales force to dermatologists, plastic surgeons, and aesthetic specialists in the United States, Canada, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.
zeltiq aesthetics inc (ZLTQ) Top Compensated Officers
zeltiq aesthetics inc (ZLTQ) Key Developments
ZELTIQ provided revenue guidance for the first half 2013. The company guides revenue to being flat in the first half of the year, partly because of all of these changes that it is implementing, it is still holding to that guidance.
ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported revenues of $19,982,000 compared to $17,404,000 a year ago. Loss from operations was $7,465,000 compared to $10,337,000 a year ago. Loss before provision for income taxes was $7,475,000 compared to $10,325,000 a year ago. Net loss was $7,482,000 or $0.21 per basic and diluted share compared to $10,345,000 or $0.30 per basic and diluted share a year ago. The company reiterating it’s previously stated financial guidance for the full year 2013. Revenue growth of approximately 10%, Consumable revenue between 45% to 50% of total revenue, gross margin of approximately 66%, operating expenses between 97% to 100% of total revenue and weighted average basic shares of common stock outstanding of approximately 36 million.
ZELTIQ Aesthetics, Inc., Q1 2013 Earnings Call, Apr 25, 2013
| Recently Viewed | |||
| ZLTQ:US | $5.07 USD | +0.10 | |
| Company | Last | Change |
| AtriCure Inc | $9.07 USD | +0.02 |
| Cutera Inc | $9.09 USD | -0.04 |
| Lutronic Corp | 11,100 KRW | +250.00 |
| Palomar Medical Technologies Inc | $13.42 USD | -0.07 |
| Vascular Solutions Inc | $15.51 USD | +0.11 |
| View Industry Companies | ||
Industry Analysis
ZLTQ
Industry Average
| Valuation | ZLTQ | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.3x |
|
| Price/Book | 2.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.7x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact ZELTIQ AESTHETICS INC, please visit www.coolsculpting.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








